Results from the OCEANIC-STROKE trial show that the investigational Factor XIa inhibitor, asundexian, not only reduces the ...

Researchers have found in a new study that use of Oral bisphosphonate in adults with osteoporosis was not linked to a reduced ...

For more than two decades, colonoscopy has been promoted as the gold standard for colorectal cancer screening. Policy makers ...

Ez-PAVE delivers the first direct trial evidence that targeting LDL below 55 mg/dL is superior to below 70 mg/dL in ASCVD ...

Also from ARVO: HDL and AMD risk in women, statin use and glaucoma risk ...

A new study published in the Journal of the American Medical Association showed that abelacimab, a factor XI inhibitor, consistently reduced bleeding relative to rivaroxaban across all age ...

I felt that it just wasn't worth all the aches and pains.

New research to be presented at the European Congress on Obesity (ECO2026) in Istanbul, Turkey (12–15 May) shows that ...

Objectives Owing to the underrepresentation of early-stage disease in randomised trials and inconsistent clinical evidence, ...

Updated data from the NordICC trial are consistent with previous results, while subgroup analyses provide new insights.